Labcorp has introduced a new rapid diagnostic tool designed to detect fentanyl exposure in clinical environments. The Fentanyl Urine Visual Test, recently cleared by the U.S. Food and Drug Administration, can identify fentanyl use within a 48-hour window and delivers results in approximately 10 minutes.
Built for use in emergency departments, hospitals, and clinics, this test aims to support faster clinical decision-making in situations where timely detection is critical. Its quick turnaround may help providers respond more effectively to suspected opioid exposure and improve patient management in urgent care settings.